Enrica Ee Kar Tan,Richard Hopkins,Chrissie K. Lim,Saumya Jamuar,Christina Ong,Koh Cheng Thoon,Mark J.A. Koh,Eun Myoung Shin,Derrick Wen Quan Lian,Madhushanee Weerasooriya,Christopher Z.W Lee,Andreas Alvin Purnomo Soetedjo,Chang Siang Lim,Veronica B. Au,Edmond Chua,Hui Yin Lee,Leigh Ann Jones,Sharmy Jennifer James,Nivashini Kaliaperumal,Jeffrey Kwok,Ee Shien Tan,Biju Thomas,Lena Ho,Lynn Wu,Anna-Marie Fairhurst,Florent Ginhoux,Adrian K.K. Teo,Yongliang Zhang,Kok Haur Ong,Weimiao Yu,Byrappa Venkatesh,Vinay Tergaonkar,Bruno Reversade,Keh-Chuang Chin,Ah Moy Tan,Woei Kang Liew,John E. Connolly,Enrica E.K. Tan,Richard A. Hopkins,Saumya S. Jamuar,Koh C. Thoon,Eun Mong Shin,Derrick W.Q. Lian,Christopher Z.W. Lee,Andreas Alvin Pumomo Soetedjo,Veonice B. Au,Sharmy S. James,Jeffery Kwok,Lynn Xue Wu,Anna Marie Fairhurst,Yong Liang Zhang,Kok Huar Ong,Keh Chuang Chin

Abstract:Although IKK-β has previously been shown as a negative regulator of IL-1β secretion in mice, this role has not been proven in humans. Genetic studies of NF-κB signaling in humans with inherited diseases of the immune system have not demonstrated the relevance of the NF-κB pathway in suppressing IL-1β expression. Here, we report an infant with a clinical pathology comprising neutrophil-mediated autoinflammation and recurrent bacterial infections. Whole-exome sequencing revealed a de novo heterozygous missense mutation of <i>NFKBIA</i>, resulting in a L34P IκBα variant that severely repressed NF-κB activation and downstream cytokine production. Paradoxically, IL-1β secretion was elevated in the patient's stimulated leukocytes, in her induced pluripotent stem cell–derived macrophages, and in murine bone marrow–derived macrophages containing the L34P mutation. The patient's hypersecretion of IL-1β correlated with activated neutrophilia and liver fibrosis with neutrophil accumulation. Hematopoietic stem cell transplantation reversed neutrophilia, restored a resting state in neutrophils, and normalized IL-1β release from stimulated leukocytes. Additional therapeutic blockade of IL-1 ameliorated liver damage, while decreasing neutrophil activation and associated IL-1β secretion. Our studies reveal a previously unrecognized role of human IκBα as an essential regulator of canonical NF-κB signaling in the prevention of neutrophil-dependent autoinflammatory diseases. These findings also highlight the therapeutic potential of IL-1 inhibitors in treating complications arising from systemic NF-κB inhibition.

Negative regulation of NF-κB p65 activity by serine 536 phosphorylation

Repression of Gene Expression by Unphosphorylated Nf-Kappa B P65 Through Epigenetic Mechanisms

Inducible Phosphorylation of NF-κB p65 at Serine 468 by T Cell Costimulation Is Mediated by IKKϵ*

Phosphorylation of RelA/p65 on Serine 536 Defines an IκBα-independent NF-κB Pathway*

Phosphorylation of Serine 536 of p65(RelA) Downregulates Inflammatory Responses

Identification of a Novel Serine/threonine Kinase That Inhibits TNF-induced NF-κB Activation and P53-Induced Transcription

The Regulation of NF-κB Subunits by Phosphorylation

Post-activation Turn-off of NF-κB-dependent Transcription Is Regulated by Acetylation of p65

Mechanisms of NF-κB p65 and strategies for therapeutic manipulation

NF-κB is a Negative Regulator of IL-1β Secretion As Revealed by Genetic and Pharmacological Inhibition of IKKβ

Molecular mechanism of IKK catalytic dimer docking to NF-κB substrates

Negative Regulation of NF- B Signaling by PIAS1

Selective Regulation of a Defined Subset of Inflammatory and Immunoregulatory Genes by an NF-κB p50-IκBζ Pathway

Role of Lysine Methylation of NF-κB in Differential Gene Regulation

A NIK-SIX Signalling Axis Controls Inflammation by Targeted Silencing of Non-Canonical NF-κB.

Transcriptional repression of NFKBIA triggers constitutive IKK‐ and proteasome‐independent p65/RelA activation in senescence

Selective regulation of a defined subset of inflammatory and immunoregulatory genes by an NF-{kappa}B p50-I{kappa}B{zeta} pathway

Acetylation of p65 at lysine 314 is important for late NF-κB-dependent gene expression

Phosphorylation of the Regulators, a Complex Facet of NF-κB Signaling in Cancer

Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome

Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency